Mission
THE RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE (READDI) IS A NONPROFIT BIOTECHNOLOGY ORGANIZATION DEDICATED TO PREVENTING GLOBAL CATASTROPHES CAUSED BY VIRUSES AND A LEADER IN THE THERAPEUTICS PILLAR OF THE 3-PRONGED PANDEMIC PREPAREDNESS AND RESPONSE STRUCTURE OF IPPS.
Executive compensation, broken down
Form 990 · Schedule J · 7 reported individuals · Filing year 2023
Base salaryBonusOther compensationBenefits
| Base salary | Bonus | Other compensation | Benefits | Executive compensation | |
|---|---|---|---|---|---|
Executive VP of Business executive vice president $101k | |||||
Board Member board member $101k | |||||
Board Member board member $89k | |||||
Board Member board member $79k | |||||
Board Member board member $60k | |||||
Board Member board member $46k | |||||
Plus 6 unpaid individuals.
Top compensation, year by year
From $95k in 2022 to $287k in 2023.
$95k
2022
$287k
2023
$95k
2022
$287k
2023
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.